Phytochemical fingerprinting of Tagetes patulla essential oil and determination of antioxidant,anti AGEs potential by using in vitro and integrated computational analysis
Restricted accessResearch articleFirst published online May, 2026
Phytochemical fingerprinting of Tagetes patulla essential oil and determination of antioxidant,anti AGEs potential by using in vitro and integrated computational analysis
Advance glycation end products (AGEs) and very crucial in development of diabetic complications since these are main reason for protein structure deformation. We investigated Tagetes patula (T. patula) essential oil (EO) for its AGEs inhibitory potential using computational (ADMET, docking) and experimental (antioxidant, Anti AGEs) validation. The caryophyllene (31.67%), β-caryophyllene (39.49%) and α -cedrene (16.21%) were major compounds noticed in GCMS analysis. Molecular docking with transcription regulators 3CJJ, 3TOP and 4F5S showed a stable complex formation with ligands. A significant lowering of oxidative stress was noticed in H2O2 inhibition (62.3 ± 2.4), DPPH scavenging (22.1 ± 0.12) and FRAP assays (217 ± 16.7 µg AAE/g). The EO showed a substantial α-glucosidase (IC50 0.094 mg/mL) and AGEs inhibition in oxidative (IC50 1.78 mg/mL) and non-oxidative (IC50 1.4 mg/mL) modes. Further in mechanistic studies a momentous results was recorded. It was this concluded that T. patula (EO) can be used for management of diabetes and AGEs and this is due to high terpenoid contents that posess significant antioxidant potential. Further in vivo and formulation design studies are proposed.
RungratanawanichWQuYWangX, et al.Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Exp Mol Med2021; 53: 168–188.
2.
HenningCGlombMA. Pathways of the maillard reaction under physiological conditions. Glycoconj J2016; 33: 499–512.
3.
AbateGMarzianoMRungratanawanichW, et al.Aggregation and filament formation. J Biol Chem2007; 282: 6984–6991.
4.
ByunKYooYSonM, et al.Advanced glycation end-products produced systemically and by macrophages: a common contributor to inflammation and degenerative diseases. Pharmacol Ther2017; 177: 44–55.
5.
PerroneAGiovinoABennyJ, et al.Advanced glycation End products (AGEs): biochemistry, signaling, analytical methods, and epigenetic effects. Oxid Med Cell Longev2020; 2020: 3818196.
MengstieMAChekol AbebeEBehaile TeklemariamA, et al.Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. Front Mol Biosci2022; 15: 1002710.
8.
RheeSYKimYS. The role of advanced glycation end products in diabetic vascular complications. Diabetes Metab J2018; 42: 188–195.
9.
AragnoMMastrocolaR. Dietary sugars and endogenous formation of advanced glycation endproducts: emerging mechanisms of disease. Nutrient2017; 9: E385.
10.
Luevano-ContrerasCChapman-NovakofskiK. Dietary advanced glycation end products and aging. Nutrients2010; 2: 1247–1265.
11.
VlassaraHUribarriJ. Glycoxidation and diabetic complications: modern lessons and a warning?Rev Endocr Metab Disord2004; 5: 181–188.
12.
UribarriJ, et al.Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci2007; 62: 427–433.
13.
TurnerDP. Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity. Cancer Res2015; 75: 1925–1929.
14.
ChanCMHuangDYHuangYP, et al.Methylglyoxal induces cell death through endoplasmic reticulum stress-associated ROS production and mitochondrial dysfunction. J Cell Mol Med2016; 20: 1749–1760.
15.
TwaijBMHasanMN. Bioactive secondary metabolites from plant sources: types, synthesis, and their therapeutic uses. Int J Plant Biol2022; 13: 4–14.
16.
Dzib-GuerraWDEscalante-ErosaFGarcía-SosaK, et al.Anti-Advanced glycation End-product and free radical scavenging activity of plants from the yucatecan Flora. Pharmacognosy Res2016; 8: 276–280.
17.
Grzegorczyk-KarolakIGołąbKGburekJ, et al.Inhibition of advanced glycation End-product formation and antioxidant activity by extracts and polyphenols from Scutellaria alpina L. And S. altissima L. Molecules2016; 21: 39.
18.
AnwarSKhanSAlmatroudiA, et al.A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds. Mol Biol Report2021; 48: 787–805.
19.
KuhlaBHaaseCFlachK, et al.Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. J Biol Chem2007; 282: 6984–6991.
20.
FaiziSSiddiqiHBanoS, et al.Antibacterial and antifungal activities of different parts of Tagetes patula: preparation of patulatin derivatives. Pharm Biol2008; 46: 309–320.
21.
LimTK.Tagetes patula, In Edible medicinal and non-medicinal plants, Dordrecht: Publ. Springer, 7, 2014, pp. 456–468. Longev. 1–10.
22.
AatiHYEmamMAl-QahtaniJ, et al.Chemical composition of Tagetes patula flowers essential oil and hepato-therapeutic effect against carbon tetrachloride-induced toxicity (in-vivo). Molecules2022; 27: 7242.
23.
KafaltiyaMLohaniHBhandariU, et al.Chemical composition, antioxidant and antimicrobial potential of the essential oils from aerial parts of Tagetes patula L. At different phenological stages. J Essent Oil-Bearing Plants2022; 25: 495–507.
24.
De Sá FilhoJCFDe Castro NizioDADe OliveiraAMS, et al.Geographic location and seasonality affect the chemical composition of essential oils of Lippia alba accessions. Indust Crop Prod2022; 188: 115602.
25.
IltafMNiazSIMajeedMK, et al.DFT, GC-MS analysis and biological evaluation of Limbarda crithmoides L. Dumort essential oil; an important edible halophyte grown in Pakistan. Nat Prod Res2024; 1: 1–8.
26.
BouoneYOBouzinaAAoufNE. Synthesis, molecular docking analysis, ADMET and drug likeness prediction of a benzenesulfonamide derivative analogue of SLC-0111. In Med Sci Forum2022; 14: 24.
27.
Naz QaisraniRIram NiazSBanoR, et al.Integrative in silico and in vitro analysis of Pinus roxburghii essential oil: unveiling its antioxidant, antidiabetic, and antiglycation potential. Front Pharmacol2025; 16: 1554562.
28.
TrottOOlsonAJ. Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient and multithreading. J Comput Chem2010; 31: 455–461.
29.
AryalSBaniyaMKDanekhuK, et al.Total phenolic content, flavonoid content and antioxidant potential of wild vegetables from western Nepal. Plants (Basel)2019; 8: 96.
30.
KutKTamaAFurdakP, et al.Generation of hydrogen peroxide and phenolic content in plant-material-based beverages and spices. Processes2024; 12: 66.
31.
BaliyanSMukherjeeRPriyadarshiniA, et al.Determination of antioxidants by DPPH radical scavenging activity and quantitative phytochemical analysis of Ficus religiosa. Molecules2022; 27: 1326.
32.
HeckmannMStadlbauerVDrotarovaI, et al.Identification of oxidative-stress-reducing plant extracts from a novel extract library—comparative analysis of cell-free and cell-based in vitro assays to quantitate antioxidant activity. Antioxidants2024; 13: 97.
33.
TelagariMHullattiK. In-vitro α-amylase and α-glucosidase inhibitory activity of Adiantum caudatum linn. And Celosia argentea linn. Extracts and fractions. Indian J Pharmacol2015; 47: 425–429.
34.
AnwarLAliSAKhanS, et al.Fenugreek seed ethanolic extract inhibited formation of advanced glycation end products via scavenging reactive carbonyl intermediates. Heliyon2023; 9: e16866.
35.
MiroliaeiMAminjafariAŚlusarczykS, et al.Inhibition of glycation-induced cytotoxicity, protein glycation, and activity of proteolytic enzymes by extract from Perovskia atriplicifolia roots. Pharmacogn Mag2017; 13: S676–S683.
36.
SindhujaAVimalavathiniRRKavimaniS. In silico docking studies of antiglycation activity of isorhamnetin on molecular proteins of advanced glycation end product (AGE) pathway. Biomed Pharmacol J2021; 14: 2299–2307.
37.
AminAHanifMRafeyA, et al.Sesquiterpene coumarins from Ferula narthex 15-LOX, α-glucosidase inhibition and molecular docking studies. Revista Brasileira de Farmacognosia2020; 30: 12–17.
38.
MardliyatiESetyawatiDRAnsariASAA, et al.In silico study of aluminum phosphate as vaccine adjuvants: exploring the binding interaction of three structures of aluminum phosphate with lysozyme and bovine Serum albumin. Biointerface Res Appl Chem2024; 14: 1–17.
39.
TaguchiKFukamiK. RAGE Signaling regulates the progression of diabetic complications. Front Pharmacol2023; 14: 1128872.
40.
Julio-GonzalezLCMorenoFJJimenoML, et al.Hydrolysis and transglycosylation activities of glycosidases from small intestine brush-border membrane vesicles. Food Res Int2021; 139: 109940.
41.
KhanMWAl OtaibiAAl-ZahraniSA, et al.Experimental and theoretical insight into resistance to glycation of bovine serum albumin. J Mol Struct2021; 1230: 129645.
42.
FallehHBen JemaaMSaadaM, et al.Essential oils: a promising eco-friendly food preservative. Food Chem2020; 330: Article 127268.
43.
HyldgaardMMygindTMeyerRL. Essential oils in food preservation: mode of action, synergies, and interactions with food matrix components. Front Microbiol2012; 3: 12.
44.
MasyitaASariRMAstutiAD, et al.Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chemistry X2022; 13: 100217.
45.
SzarkaSZHethelyiELemberkovicsÉ, et al.GC And GC-MS studies on the essential oil and thiophenes from Tagetes patula L. Chromatographia2006; 63: S67–S73.
46.
MouhidLCorzo-MartínezMTorresC, et al.Improving in vivo efficacy of bioactive molecules: an overview of potentially antitumor phytochemicals and currently available lipid-based delivery systems. J Oncol2017; 1: 7351976.
47.
StevanovicZDSieniawskaEGlowniakK, et al.Natural macromolecules as carriers for essential oils: from extraction to biomedical application. Front Bioeng Biotechnol2020; 25: 63.
48.
Ou-YangSLuJKongX, et al.Computational drug discovery. Acta Pharmacol Sin2012; 33: 1131–1140.
49.
Sohlenius-SternbeckAKTereliusY. Evaluation of ADMET predictor in early discovery drug metabolism and pharmacokinetics project work. Drug Metab Dispos2022; 50: 95–104.
50.
HanYZhangJHuCQ, et al.In silico ADME and toxicity prediction of ceftazidime and its impurities. Front Pharmacol2019; 24: 34.
51.
DainaAMichielinOZoeteV. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep2017; 7: 42717.
52.
PatilRDasSStanleyA, et al.Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS One2010; 5: e12029.
53.
VaidyanathanSSambasALienCH, et al.Modelling, control methods and applications of chaotic oscillators. Discerete Dyn Nat Soc2023; 2023: 802412.
54.
LiJMaXGuoS, et al.A hydrophobic-interaction-based mechanism triggers docking between the SARS-CoV-2 spike and angiotensin-converting enzyme 2. Glob Chall2020; 4: 2000067.
55.
VedadghavamiAHeTZhangC, et al.Charge-based drug delivery to cartilage: hydrophobic and not electrostatic interactions are the dominant cause of competitive binding of cationic carriers in synovial fluid. Acta Biomater2022; 151: 278–289.
56.
Mohammadi-CheraghabadiMHazratiS. Terpenoids, steroids, and phenolic compounds of medicinal plants. Phytochemicals in Medicinal Plants: Biodiversity, Bioactivity And Drug Discovery2023; 105: 9783110791891–005.
57.
YangXJDangBFanMT. Free and bound phenolic compound content and antioxidant activity of different cultivated blue highland barley varieties from the qinghai-Tibet plateau. Molecules2018; 23: 879.
58.
Gutiérrez-Del-RíoILópez-IbáñezSMagadán-CorpasP, et al.Terpenoids and polyphenols as natural antioxidant agents in food preservation. Antioxidants (Basel)2021; 10: 1264.
TsimogiannisDBimpilasAOreopoulouV. DPPH Radical scavenging and mixture effects of plant o-diphenols and essential oil constituents. Eur J Lipid Sci Technol2017; 119: 16003473.
61.
SassoFCSimeonVGalieroR, et al.NID-2 study group investigators. The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial. Cardiovasc Diabetol2022; 21: 35.
62.
ZhaoMWangSZuoA, et al.HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury. Cell Mol Biol Lett2021; 26: 40.
63.
KimSD. Glucosidase inhibitor from Buthus martensi Karsch.Food Chem2013; 136: 297–300.
64.
MajouliKBesbes HlilaMHamdiA, et al.Antioxidant activity and α-glucosidase inhibition by essential oils from Hertia cheirifolia (L.). Ind Crops Prod2016; 82: 23–28.
65.
HashieshHMMeeranMFAzimullahSS, et al.β-caryophyllene, a CB2 receptor agonist alleviates diabetic cardiomyopathy via inhibiting AGE/RAGE-induced oxidative stress, fibrosis, and inflammasome activation. J Pharmacol Exp Ther2023; 385: 303.
66.
PaudelPPrajapatiRLimHJ, et al.Anti-glycation, anti-β-amyloid aggregation, and antioxidant effect of Cassia seed-derived secondary metabolites. J Food Biochem2023; 2023: 868031.
67.
BtissamRRajaeRAminaA, et al.In vitro study of anti-glycation and radical scavenging activities of the essential oils of three plants from Morocco: Origanum compactum, Rosmarinus officinalis and Pelargonium asperum. Pharmacognosy Journal2015; 7: 124–135.
68.
AnFBaiYXuanX, et al.1, 8-Cineole ameliorates advanced glycation end products-induced Alzheimer’s disease-like pathology in vitro and in vivo. Molecules2022; 27: 3913.
